-transparent.png){kind=logo}
In this multi-institutional phase II study, VM-26 or Teniposide was administered to forty-two patients with advanced colorectal cancer. Patients were initially treated at 60 mg/M2 daily for 5 days with dose adjustments depending on toxicity. One complete response and one partial response were observed lasting six and four months respectively. Leukopenia was severe in 40% of patients. No drug related deaths were seen. In this Southwest Oncology Group (SWOG) study, VM-26 appeared to have minimal benefit in advanced colorectal cancer.
Related Publications
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
November 1993,
Investigational new drugs,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
March 1998,
Cancer,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
September 1997,
Cancer,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
August 1990,
Investigational new drugs,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
January 1985,
Cancer treatment reports,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
February 1991,
American journal of clinical oncology,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
January 1990,
Investigational new drugs,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
January 1984,
Investigational new drugs,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
December 1987,
Cancer treatment reports,
N Oishi, and
T R Fleming, and
L Laufman, and
J S Ungerleider, and
R B Natale, and
A B Einstein, and
D D Von Hoff, and
J S Macdonald
January 1994,
Cancer biotherapy,
